<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04219605</url>
  </required_header>
  <id_info>
    <org_study_id>0120-19-COM1</org_study_id>
    <nct_id>NCT04219605</nct_id>
  </id_info>
  <brief_title>Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions</brief_title>
  <official_title>Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the diagnostic performance of the Gyni™ device to detect different vaginitis&#xD;
      conditions by comparison to microscopic diagnosis and related lab tests.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During gynecological exams, vaginal discharge samples will be are taken for testing the pH&#xD;
      level, microscopic examination and laboratory examinations (vaginal cultures and sexually&#xD;
      transmitted infections).&#xD;
&#xD;
      One additional sample will be taken intended for the Gyni™ system diagnosis. This additional&#xD;
      examination will be performed in the clinic by pulling the cytobrush through a dedicated&#xD;
      cartridge and scanning it in the Gyni table-top scanner. The result diagnosis will be&#xD;
      anonymously kept in the cloud.&#xD;
&#xD;
      The diagnosis suggested by the Gyni system will not be visible to the physician in order to&#xD;
      prevent any bias. Results from the physician, from the device and from the lab will be&#xD;
      summarized and compared by the chief investigator&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic performance</measure>
    <time_frame>12 months</time_frame>
    <description>Specificity and sensitivity of the device performance in regard to vaginitis conditions</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bacterial Vaginosis</condition>
  <condition>Candida Albicans Vulvovaginitis</condition>
  <condition>Candida Vulvovaginitis</condition>
  <condition>Trichomonas Vaginitis</condition>
  <condition>Atrophic Vaginitis</condition>
  <condition>Desquamative Inflammatory Vaginitis</condition>
  <arm_group>
    <arm_group_label>Symptomatic vaginitis patients</arm_group_label>
    <description>Symptomatic patients evaluated in the clinic for vulvovaginal symptoms.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with vulvovaginal symptoms&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with vaginal complaints: Discharge, Malodor, Itching, Irritation, Dyspareunia,&#xD;
             Pain&#xD;
&#xD;
          -  Age &gt;= 18y&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18y&#xD;
&#xD;
          -  Not eligible to sign an informed consent&#xD;
&#xD;
          -  Vaginal discharge samples found microscopically not interpret-able by the investigator&#xD;
             due to patient using vaginal creams, ointments, lubricants or sperm presence.&#xD;
&#xD;
          -  During menstruation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>The study examine a diagnostic test for vaginal inflammations (vaginitis) which is only applicable to female patients.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avraham Ben Chetrit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clalit HMO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahinoam Lev-Sagie, MD</last_name>
    <phone>972-2-5889551</phone>
    <email>levsagie@netvision.net.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clalit HMO</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahinoam Lev-Sagie, MD</last_name>
      <email>levsagie@netvision.net.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 5, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Trichomonas Vaginitis</mesh_term>
    <mesh_term>Candidiasis, Vulvovaginal</mesh_term>
    <mesh_term>Vaginitis</mesh_term>
    <mesh_term>Atrophic Vaginitis</mesh_term>
    <mesh_term>Vulvovaginitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

